Standardized screening and management pathways for depression in patients with cardiovascular disease offer the potential for early identification and improved health outcomes.
Standardized screening and management of depression in patients with cardiovascular disease is crucial due to its high prevalence and negative impact on clinical outcomes and adherence.
Depression is a common problem in patients with cardiovascular disease (CVD) and is associated with increased mortality, excess disability, healthcare expenditures, and reduced quality of life. Depression is present in 1 in 5 patients with coronary artery disease, peripheral artery disease, and heart failure. Depression complicates the optimal management of CVD by worsening cardiovascular risk factors and decreasing adherence to healthy lifestyles and evidence-based medical therapies. As such, standardized screening pathways for depression in patients with CVD offer the potential for early identification and optimal management of depression to improve health outcomes. Unfortunately, the burden of depression in patients with CVD is under-recognized; as a result, screening and management strategies targeting depression have been poorly implemented in patients with CVD. In this review, we discuss a practical approach for the screening and management of depression in patients with CVD.
Jha et al. (Mon,) conducted a review in Cardiovascular disease and depression. Screening and management of depression was evaluated. Standardized screening and management pathways for depression in patients with cardiovascular disease offer the potential for early identification and improved health outcomes.